| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 173.30▼ | 173.06▼ | 172.91▼ | 167.32▲ | 165.16▲ |
| MA10 | 173.20▼ | 172.79▼ | 170.54▲ | 166.46▲ | 162.69▲ |
| MA20 | 173.30▼ | 170.18▲ | 171.12▲ | 165.14▲ | 164.67▲ |
| MA50 | 172.94▼ | 169.18▲ | 167.27▲ | 162.91▲ | 148.92▲ |
| MA100 | 170.62▲ | 167.24▲ | 165.77▲ | 163.25▲ | 143.59▲ |
| MA200 | 171.33▲ | 165.62▲ | 163.50▲ | 148.89▲ | 141.80▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.131▼ | 0.148▲ | 0.249▲ | 0.727▲ | -0.700▼ |
| RSI | 37.023▼ | 53.679▲ | 57.827▲ | 58.651▲ | 59.652▲ |
| STOCH | 47.736 | 74.985 | 79.723 | 55.066 | 41.434 |
| WILL %R | -90.543▼ | -23.806▲ | -32.303 | -26.942 | -49.952 |
| CCI | -235.275▼ | 41.415 | 59.243 | 127.523▲ | 16.416 |
| ▲ RSI&MACD | $ICUI MACD cross and RSI above 55 | Set Alert |
| ▲ RSI&VOL | $ICUI RSI Cross Up and Volume | Set Alert |
| RSI | $ICUI RSI(14) Crossed Above 50 | Set Alert |
| ▲ MA | $ICUI MA(20) Crossed Above MA(50) | Set Alert |
| ▲ MACD | $ICUI MACD(12,26,9) Crossed Above Signal Line | Set Alert |
| MA | $ICUI Price Crossed Above MA(50) | Set Alert |
| MA | $ICUI Price Crossed Above MA(26) | Set Alert |
| MA | $ICUI Price Crossed Above MA(13) | Set Alert |
| MA | $ICUI Price Crossed Above MA(7) | Set Alert |
| ▲ GAP | $ICUI Open Gap Up %3 | Set Alert |
| ▲ GAP | $ICUI Open Gap Up %2 | Set Alert |
| ▲ BREAK | $ICUI Price Breaks 30 Days High | Set Alert |
| ▲ BREAK | $ICUI Price Breaks 20 Days High | Set Alert |
| ▲ BREAK | $ICUI Price Breaks 10 Days High | Set Alert |
|
Friday, November 06, 2026 12:30 AM
ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 2026 Jefferies Global ...
|
|
Thursday, November 05, 2026 09:39 PM
Medical device company ICU Medical (NASDAQ:ICUI) announced in Q3 2026, with sales up 5.1% year on year to $560.4 million. Its non-GAAP profit of $2.44 per share was 13.6% above analysts’ consensus ...
|
|
Thursday, November 05, 2026 03:55 PM
ICU Medical Q3 2026 earnings: record infusion growth, stronger margins, debt paydown, and guidance near the high end.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/26 | 165.00 | 174.82 | 164.38 | 172.11 | 464,800 |
| 05/11/26 | 173.99 | 177.45 | 164.30 | 167.65 | 528,204 |
| 04/11/26 | 167.01 | 175.325 | 166.21 | 172.62 | 446,881 |
| 03/11/26 | 163.00 | 166.475 | 160.39 | 161.83 | 297,797 |
| 02/11/26 | 166.66 | 167.325 | 161.41 | 162.38 | 309,977 |
| 30/10/26 | 169.64 | 170.00 | 163.145 | 163.78 | 216,557 |
| 29/10/26 | 168.85 | 169.65 | 166.1634 | 168.65 | 202,492 |
| 28/10/26 | 161.63 | 166.645 | 157.63 | 166.39 | 155,808 |
| 27/10/26 | 166.41 | 166.41 | 162.97 | 163.20 | 323,145 |
| 26/10/26 | 166.42 | 168.48 | 162.88 | 165.96 | 153,950 |
|
|
||||
|
|
||||
|
|